{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:13:22Z","timestamp":1778753602295,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-06953-x","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:38:33Z","timestamp":1775806713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Avapritinib for targeting KIT D816V-mutated acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplant with extramedullary and central nervous system involvement"],"prefix":"10.1007","volume":"105","author":[{"given":"Marco","family":"Frigeni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Algarotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Salmoiraghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Belotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Milani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Pavoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orietta","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Gotuzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Rambaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Lussana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"6953_CR1","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1007\/s00277-022-04897-6","volume":"101","author":"J Yin","year":"2022","unstructured":"Yin J, Zhu F, Zhang ZB et al (2022) Rapid and deep response to avapritinib in heavily treated acute myeloid leukemia with t (8;21) and KIT mutation. Ann Hematol 101:2347\u20132350. https:\/\/doi.org\/10.1007\/s00277-022-04897-6","journal-title":"Ann Hematol"},{"key":"6953_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41409-023-01973-x","volume":"58","author":"J Kong","year":"2023","unstructured":"Kong J, Zheng FM, Wang ZD et al (2023) Avapritinib is effective for treatment of minimal residual disease in acute myeloid leukemia with t (8;21) and kit mutation failing to immunotherapy after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl 58:777\u2013783. https:\/\/doi.org\/10.1038\/s41409-023-01973-x","journal-title":"Bone Marrow Transpl"},{"key":"6953_CR3","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1080\/10428194.2022.2064994","volume":"63","author":"S Xue","year":"2022","unstructured":"Xue S, Huang W, Liu F et al (2022) Rapid response to avapritinib of acute myeloid leukemia with t(8;21) and KIT mutation relapse post allo-HSCT. Leuk Lymphoma 63:2247\u20132250. https:\/\/doi.org\/10.1080\/10428194.2022.2064994","journal-title":"Leuk Lymphoma"},{"key":"6953_CR4","doi-asserted-by":"publisher","unstructured":"Getz TM, Bakirhan K, Seropian S, Shallis RM (2025) Avapritinib monotherapy induces rapid and deep remission of heavily treated, KIT D816H-mutated t(8;21) acute myeloid leukemia, a case report and literature review. Ann Hematol 1\u20134. https:\/\/doi.org\/10.1007\/s00277-025-06388-w","DOI":"10.1007\/s00277-025-06388-w"},{"key":"6953_CR5","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1182\/blood.2021014612","volume":"140","author":"J Gotlib","year":"2022","unstructured":"Gotlib J, Reiter A, DeAngelo DJ (2022) Avapritinib for advanced systemic mastocytosis. Blood 140:1667\u20131673. https:\/\/doi.org\/10.1182\/blood.2021014612","journal-title":"Blood"},{"key":"6953_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3324\/haematol.2012.073189","volume":"98","author":"AC Harris","year":"2013","unstructured":"Harris AC, Kitko CL, Couriel DR et al (2013) Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes. Haematologica 98:179\u2013184. https:\/\/doi.org\/10.3324\/haematol.2012.073189","journal-title":"Haematologica"},{"key":"6953_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-10831-7","volume":"12","author":"H Zhao","year":"2022","unstructured":"Zhao H, Dong Z, Wan D et al (2022) Clinical characteristics, treatment, and prognosis of 118 cases of myeloid sarcoma. Sci Rep 12:1\u201310. https:\/\/doi.org\/10.1038\/s41598-022-10831-7","journal-title":"Sci Rep"},{"key":"6953_CR8","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.3324\/haematol.2023.284858","volume":"109","author":"S Blum","year":"2024","unstructured":"Blum S, Chalandon Y, Labopin M et al (2024) Incidence and outcome of central nervous system relapse after hematopoietic stem cell transplantation in patients suffering from acute myeloid leukemia and acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society. Haematologica 109:2346\u20132350. https:\/\/doi.org\/10.3324\/haematol.2023.284858","journal-title":"Haematologica"},{"key":"6953_CR9","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ccell.2025.02.018","volume":"43","author":"L Mayr","year":"2025","unstructured":"Mayr L, Neyazi S, Schwark K et al (2025) Effective targeting of PDGFRA-altered high-grade glioma with avapritinib. Cancer Cell 43:740\u2013756e8. https:\/\/doi.org\/10.1016\/j.ccell.2025.02.018","journal-title":"Cancer Cell"},{"key":"6953_CR10","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1007\/s00277-024-05810-z","volume":"103","author":"Q Wang","year":"2024","unstructured":"Wang Q, Hu Y, Gao L et al (2024) Pediatric acute myeloid leukemia with t(8;21) and KIT mutation treatment with avapritinib post-stem cell transplantation: a report of four cases. Ann Hematol 103:3795\u20133800. https:\/\/doi.org\/10.1007\/s00277-024-05810-z","journal-title":"Ann Hematol"},{"key":"6953_CR11","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/nejmoa1614359","volume":"377","author":"RM Stone","year":"2017","unstructured":"Stone RM, Mandrekar SJ, Sanford BL et al (2017) Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation. N Engl J Med 377:454\u2013464. https:\/\/doi.org\/10.1056\/nejmoa1614359","journal-title":"N Engl J Med"},{"key":"6953_CR12","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1200\/JCO.23.02474","volume":"42","author":"MJ Levis","year":"2024","unstructured":"Levis MJ, Hamadani M, Logan B et al (2024) Gilteritinib as Post-Transplant Maintenance for AML with Internal Tandem Duplication Mutation of FLT3. J Clin Oncol 42:1766\u20131775. https:\/\/doi.org\/10.1200\/JCO.23.02474","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06953-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06953-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06953-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:20:42Z","timestamp":1778750442000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06953-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":12,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["6953"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06953-x","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics committee approval was not required for this study, as it is a single case report. All procedures were performed in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments. Written informed consent for publication of this case report and any accompanying images was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"238"}}